Investing Acceleration of RAD204 Phase 1 dose escalation trial by admin May 12, 2025 May 12, 2025 Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com previous post Multiple New Multi-Commodity Targets next post Excellent Gold Intersections Verified at Kiimala Project You may also like Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy... May 15, 2025 Lode Gold Completes Final Tranche Financing for Total... August 9, 2025 175m @ 2.5% Copper from 7.6m, Hole Ends... May 6, 2025 Nevada Sunrise Metals: Advancing High-potential Gold & Critical Metals... November 28, 2025 Tech 5: US Lifts EDA Restrictions for China,... July 6, 2025 Kobo Resources: Unlocking West Africa’s Untapped Gold Potential August 19, 2025 Germany, Italy Face Pressure to Repatriate US$245 Billion... June 25, 2025 Gold Retreats, Equities Down as Fed Leaves Rates... July 31, 2025 Altech – Commences Selling Sodium Nickel Chloride Batteries September 30, 2025 Questcorp Mining Completes 25 Percent of Maiden Drilling... August 19, 2025